What is the ReStore™?

The ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of persons with lower limb disability due to stroke. It will be a first of its kind gait training solution.


How does it work?

The device is designed to perform ambulatory functions in rehabilitation centers under the supervision of a trained therapist for people with hemiplegia/hemiparesis due to stroke. ReStore is not intended for sports or stair climbing.

ReStore provides coordinated plantarflexion and dorsiflexion assistance to a patient’s impaired foot and ankle.

  • Power is transmitted from waist belt-mounted motors through cables to attachment points on the calf wrap and an insole which is placed in the patient’s shoe.
  • Sensors clipped to the patient’s shoes detect motion and communicate timing of the assistance.
  • Using data analytics displayed on a handheld smartphone controller, a trained therapist is able to:
    • Adjust assistance level
    • Monitor key metrics
    • Record standard gait training assessments and compare sessions


What makes ReStore different?

The ReStore is designed to be a versatile, cost effective gait therapy solution which offers:

  • Light, soft components to facilitate natural gait pattern – The non-rigid device is designed to allow free movement as opposed to a dictated gait pattern.
  • Real-time analytics for enhanced session control and recording key metrics – Information and adjustability in the therapist’s hands allow them to optimize the session, and track and report a patient’s progress.
  • Coordinated Plantar/Dorsi flexion assistance – ReStore is the only device that provides both powered dorsiflexion to address foot drop and plantarflexion to assist with push-off during forward propulsion.

For informational purposes only. ReStore is not available for commercial sale. It will require appropriate regulatory clearance.
To learn more, visit our website at or contact us at


When will it be available?

The ReStore exo-suit is currently in clinical study at top U.S. rehabilitation hospitals. ReWalk plans to submit the device for regulatory clearance in 2019 with the goal of commercialization to rehabilitation clinics in the first half of 2019.

Click here to watch the Fox Business News video.

Click here to contact us for more information about ReStore.

Click here for more information on the multi-center clinical trial.

Share this

If you click on one of the icons listed here, your personal data will be transmitted to the selected network.